Philippe Sauvage - 15 Jul 2026 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship: Chief Financial Officer
Issuer ticker: NUVB
Reported as of: 15 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jul 2026, 18:27:20 UTC
Prior SEC filing: 24 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen Dang, Attorney-in-Fact, Attorney-in-Fact

Key filing fact

Philippe Sauvage filed Form 4 for Nuvation Bio Inc. (NUVB) on 17 Jul 2026.

Key facts

This page summarizes Philippe Sauvage's Form 4 filing for Nuvation Bio Inc. (NUVB).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 17 Jul 2026, 18:27.

Change

Previous filing in this sequence was filed on 24 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002039891 Primary reporting owner

Sauvage Philippe

Relationship: Chief Financial Officer
Address: C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK
Signature: /s/ Stephen Dang, Attorney-in-Fact, Attorney-in-Fact
Signature date: 17 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +39,999
Change %: +283%
Price: $2.17^*
Shares after: 54,130
Date: 15 Jul 2026
Ownership: Direct
Footnotes: F1

NUVB transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +1
Change %: +0%
Price: $1.97^*
Shares after: 54,131
Date: 15 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -39,999
Change %: -5.7%
Price: $0.000000^*
Shares after: 662,333
Date: 15 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 39,999
Exercise price: $2.17
Footnotes: F2

NUVB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -1
Change %: -0%
Price: $0.000000^*
Shares after: 499,999
Date: 15 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1
Exercise price: $1.97
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026.

Footnote F2

Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Footnote F3

Option vests as to 25% on the one year anniversary of February 28, 2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.